Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
156
NCT00470457
A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy
Phase: Phase 2
Role: Collaborator
Start: Jun 30, 2001
Completion: Mar 31, 2005